Red Net Moment October 28 (Correspondent Zhang Xiyu) On the morning of October 27, a 9-year-old girl Xiao Zheng, a 9-year-old girl with thalassemia hematopoietic stem cell transplant in Zhuzhou Central Hospital, was discharged from the hospital. This is not only the first case of thalassemia hematopoietic stem cell transplant patients discharged from the hospital in Zhuzhou City, but also marks that the clinical diagnosis and treatment level of the Hematology Department of the Central Hospital has reached the advanced level in China.
Xiao Zheng was diagnosed with severe β thalassemia 9 months after birth, and after the diagnosis, he began to look for a suitable donor in the Chinese bone marrow bank, but he has not been found, and has long relied on the infusion of red blood cells to replace. Hu Guoyu, director and chief physician of the Department of Hematology of the Central Hospital, introduced that mild thalassemia does not need treatment, severe β thalassemia, high-volume blood transfusion combined with iron removal therapy is the basic treatment measure, and hematopoietic stem cell transplantation is the only clinical method to cure the disease.
On October 7 this year, Xiao Zheng performed a hematopoietic stem cell transplant through the HLD semi-conjugate heterogene provided by her mother. With the full cooperation of the medical staff of the Hematology Department of the Central Hospital, the condition gradually stabilized and he was finally discharged smoothly.